Standard Molecular, Inc. is transforming patient care and development of personalized therapies through integrated genomic data. The company’s proprietary platform addresses a key pain point in the rapidly growing use of molecular testing by enabling the exchange of standardized, discrete genomic data to streamline information flow between physician practices and molecular labs.
Employees: 11-50
Founded date: 2014